our and afternoon, your of Thank everyone. right. delay We for today and full with time taking appreciate the and to year. in quarter patience respect join announcing us results the fourth good you to appreciate Devin, All you,
quarter fourth in rose to for strong quarter. total fivefold $XX.X very quarter, third of Following $XXX.X fiscal million revenue the fourth a million year's from XXXX last
to last XXXX, from segments year the and the full organic million RMS million $XXX.X increase revenues $XX.X XX% acquisitions. the from approximately with plus For growth reflecting improved contribution across our business DSA year,
fiscal to million EBITDA XX.X% revenues XX.X% in of of from Adjusted year's improved million revenues $XX.X QX total or or last for fourth quarter. $X.X total
million the For of $XX.X total EBITDA adjusted or -- from last to or $X.X revenues full from year. grew year, grew XX.X% million XX.X%
of to services evolution industries. comprehensive continued This our year the was products ongoing a growth reflective was pharmaceutical and into research and global a CRO non-clinical of very of biotech solid and provider
During the progress XXXX, will which in our to pleased business year plans shortly. we overall estimate specific acquired a we in with optimization consummated several be XXXX we growth greater have both path We to acquisitions model I'll and the to and continue began NHP created detail fiscal improve in our portfolio margins. addressing expansion what and made while disruption and discuss We're sales in our geographic of with business, believe entered temporary service offerings. and be operations sustainable 'XX a integration that our what we enhanced footprint will of of
capital deals, terminated project. Haslett not the facilities, as During began legal fees to costs recruiting operations had to charges, of also closures move we restructuring we Dublin, facilities; expenses discontinuation close, and certain other and operating Boyertown; company-wide and fourth to expenses which transactions higher integration costs, of from well did related the DSA to unexpectedly consolidation from for costs the M&A related new quarter, including validation we non-recurring services, for experience of as the financing will we from moves and Virginia acquisitions preparation and a
segments. business Let's our DSA of discussion to a RMS and brief move
$XXX.X increase $XX.X million, million, of approximately representing of our Overall, supported from revenue in generating was Organic by acquisitions. DSA XXXX. DSA of had an XX%, business growth million growth $XX.X year, revenue XX.X% incremental incremental revenue an XXXX strategic exceptional from
For to Good cytogenetics GLP, in as therapeutics. or standard to in and Practices, Maryland XXXX, bacterial of mutation conduct added evaluations capabilities studies battery genetic for new toxicology Rockville, Laboratory of and we've first-in-human capacity assays support of studies components required the vitro, already novel
and the We seeing also continue growth facility of our toxicology Rockville look buildout in business. suite genetic our and as complete developing to continued we services launch forward biotherapeutics
XXXX projects capacity in our other coming initiated will online and fiscal fiscal project completing across Boulder, early the are and expansion specifically capabilities to 'XX. a We out completing was existing enterprises, be during This build in Colorado.
We are expanding for plan but operations which XXXX. the narrowing be we'll as scheduled Colorado, well in Fort Collins, was
our facility offerings, DSA and revenue million. completed, the our third-party certain on increase service by $XX an by will services. expansions outsourcing reducing reliance also will expansions capacity while XX% DSA improve quality These efficiency our for and capacity Once these of our overall estimated
reducing acquired that overall impact and spend fiscal prospects North we expansion generate we will Conversely, can previously-announced plans our evaluate and Carolina, near-term of XXXX. our at will capital needs these our which the we our The our quick of ILS some investments expansion 'XX. growth in slowdown facility reprioritizing future. believe are our and January in does delay in not we activities in We returns
RMS of in in the contributed run year, growth when revenue incremental well above $XX.X reflecting representing segment rate revenue growth revenue our of XXXX. with XX%. the XXXX November million the entered was we in Envigo million, Organic RMS strong market approximately $XXX.X Our revenue incremental acquisition
This the enhance enhanced changes. plans, and taken this first in operations to through other and actions chance our operational year significant business. the improve margins product knowledge portfolio site of the across have optimization future We've RMS further pricing had significant a was to business, gain
ceased than and June, less X% The was made also of the was Dublin Cumberland our Virginia XXXX, property the at two sold. Cumberland in locations. end of master EBITDA. in the now were Virginia of announced have of optimization and in has total closings, We our Cumberland, to site the comprehensive progress of being in been being facility revenue completed other The RMS in significant by and from closure contribute and not facility XXXX. process the sold the customers facilities served of Since Virginia. our transferred November closure are plan. we adjusted Dublin fiscal the is revenue In facility did operations
of previously-announced XXXX. We Indianapolis by Indianapolis. June be The XXXX. in should -- Boyertown, to existing facilities Haslett, or The announced completed and now other facility of closures March activity the should facilities Michigan Pennsylvania of and be XXXX in be facilities are in process of of and will relocated closure by these two recently completed March
of proposed complete Blackthorn, we and existing in into France facilities, introduced Gannat, XXXX, which if the consolidation and U.K. also approved, XXXX We respectively. plans hope to
bit more on business. to I primate Now, our non-human a give move want detail little to
import Cambodia the As NHPs XXXX XX, is we NHPs XX% to Cambodia, of and our of to U.S. represented of imports of shipments absence from from initiated other stated Cambodia to the countries. China, of sell or over supplier release, any NHP In a imports CDC out not statistics. an although critical do on according NHPs imports, caution, have abundance from November of we continue
that are reasonably purpose-bred Cambodia after to and to only time NHPs work caught. the current not can inventory external NHPs such of we'll our and wild shipments resources internal and review from continue we our We determine possession NHP with these begin in
of from currently Inotiv we audits importing complete aware not we from not Cambodia any will suppliers. Cambodia, satisfactory of outside can import While constraints on-site our NHPs on until are
that these We complete be are in during audits communication on-site to We understand will that they we NHPs. quarter. with suppliers able be shipping expect in and Cambodian do Cambodia have to our be stated Cambodian we officials will this
was believe changes needs. industry. to Envigo to Having factor to Even BioResource. in significantly-constrained will along access this industry will We our clients' the DSA Orient critical a a our with positive lead the to shows business have to to impact our this situation with market, in and within the working business on government DSA others decision to the changes a purchase ample meet have current look our to we have desire ability access to we and NHPs believe supply, industry, the continue forward and the to need industry, implement our in with and --
quarter market backlog quoting at activity commentary, higher into fourth broader increased to a an year-end. level conditions translated and of respect during the With XXXX,
a they were and of when awards, high net experience to as due continued of of cancellations. also report abandoning to were the seen we as months backlog, we that primarily ago ready are XX As a not cancellations, new projects for in being Despite reminder, awarded XX projects risky. molecules the level which growth to expected
market seen industry some that in spending. commentary downturn biotech and We a the is seeing the funding have
our with this have been experienced few recently case We where has a clients. occasions the
conditions We continue monitor market closely. to
as recruiting, such significant. XXXX operational technology, investments we have processes, made The personnel been in areas in internal facilities,
a the nine overall over further plan, has will projects welfare. service -- We Within business, of RMS includes XX integrate allow million we begin optimization level achieve our of acquisitions We currently service believe to RMS our maintain offerings, have it and which allowed sites We investments comprehensive broaden implement the our invested in and to us business. during margins, high with animal customer to $XX.X improve will level these XXXX. closing investments us of specifically, our allow and enhance our to acquired internal the us allowed synergies. site
opportunity to also review investments operational the to our had cost addition In we've pricing. in and an XXXX,
XXXX been have customer able will the contracts which Many of fiscal pricing in to These inflationary XXXX. cost and XXXX. we to of experienced increases, in January go a amend QX As changes offset effect into result, of pricing. began we during and help
and support December approximately year. needed workforce. to XXXX, to and employment months filled. a rate rate. current XX% with all XXXX is operational hired our our are consistent successfully Overall, ended our levels, XXXX, turnover During efficiency current and growth present, to expect gains. reduce people, investment XX a we're support retention over seen last was stay increase was our -- in our growth significant leadership and the of which from able to At we XX, We've we This improvements critical positions in our growth expect XXX
what market and able years, over conditions be have to we on we four acquisitions. achieve of expect been XXXX, result less the a last in to As focused
fiscal the Services built share. for strong our digit industry over low current stated our announced state As to prudent the believe given our related activities previously on and double businesses reduced past digit Discovery for market integrating is Safety the have we We organic have which action to mid our for focus the single we of markets two business. DSA ability and expansion years. that desire believe to course high growth XXXX Assessment, has growth optimizing of we this speaks growth exceeded had and increase and and of delayed to capital to earlier, certain acquired We average also
million million, an fiscal $XXX the QX. $XXX $XXX margins QX, and nine-month in As XXXX, approximately of our adjusted for to QX includes per revenue -- $XXX QX the XX, providing $XX guidance revenue QX we disruption recent to EBITDA and Due of adjusted at for through of and during $XXX of XXXX, a of ending through The revenue of EBITDA. during year adjusted XX% NHP of of revenue EBITDA million end at for September approximately million guidance are of guidance period of chain, EBITDA least XXXX fiscal expected guidance includes XXXX. negative margin from supply million the of million range least year of million adjusted $XX QX
offerings share gains service We business. will continue market our with on to and the expanding focus growth in organic DSA
revenue growth increasing into sales to We to With backlog the improvements on look cost our efficiency we enhance fixed DSA have heading strong DSA XXXX, structure good visibility for XXXX. through on margin. leverage
the will plans. increases from market XXXX of January in margin Our RMS be gains, benefit driven our price business site expected share expansion and by implemented further the will while optimization
welfare We programs. enhancing continue to invest also animal our in
the Our from number of in sales guidance does last year. assume NHP a reduction
knowledge able additional we've short-term guidance NHP audits are are Cambodia we on during we levels. experienced of year place XXXX full from comfort our Although and importation this level to not any are We supply resume to hope levels based sales further the a and importation get on if from disruption, to expected importation quarter. could ban aware throughout take increase that
than over XX% range Even this throughout we XXXX highly price NHPs if expect could to in supply-constrained the 'XX, is to benefit for which lower total volume increases -- this XXX% between NHPs, year environment. from of
well impacted believe were positioned and we in supply achieve market in rates QX, revenue issue the we above business by expansion is Although NHP growth the margins. to
As focus on for stated we previously, opportunities. growth XXXX, margins, revenue optimizing focused and are organic acquisition and on improving less
EBITDA long-term high of growth revenue digits of margins double long-term low guide single to continue to XX% We and XX%. to
overview. that, turn ahead with financial Chief go our please I'll it Beth to With the Beth, Officer, over Financial Taylor.
